PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 40 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $122,000 | +221.1% | 53,618 | +20.3% | 0.00% | – |
| Q3 2019 | $38,000 | +40.7% | 44,569 | +62.4% | 0.00% | – |
| Q2 2019 | $27,000 | -75.2% | 27,449 | -68.3% | 0.00% | -100.0% |
| Q1 2019 | $109,000 | +87.9% | 86,723 | +313.7% | 0.00% | 0.0% |
| Q2 2018 | $58,000 | -78.7% | 20,962 | -55.1% | 0.00% | -80.0% |
| Q4 2017 | $272,000 | +174.7% | 46,718 | -0.7% | 0.01% | +150.0% |
| Q3 2017 | $99,000 | +94.1% | 47,034 | +331.9% | 0.00% | +100.0% |
| Q2 2017 | $51,000 | -61.1% | 10,891 | -34.9% | 0.00% | -75.0% |
| Q1 2017 | $131,000 | -72.8% | 16,723 | -57.4% | 0.00% | -80.0% |
| Q4 2016 | $482,000 | – | 39,299 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
| NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
| Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
| DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
| RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
| DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
| BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
| Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
| Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
| Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |